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a b s t r a c t
As a member of the retrovirus family, HIV-1 packages its RNA genome into particles and replicates through a
DNA intermediate that integrates into the host cellular genome. The multiple genes encoded by HIV-1 are
expressed from the same promoter and their expression is regulated by splicing and ribosomal frameshift.
The full-length HIV-1 RNA plays a central role in viral replication as it serves as the genome in the progeny
virus and is used as the template for Gag and GagPol translation. In this review, we summarize ﬁndings that
contribute to our current understanding of how full-length RNA is expressed and transported, cis- and trans-
acting elements important for RNA packaging, the locations and timing of RNA:RNA and RNA:Gag
interactions, and the processes required for this RNA to be packaged into viral particles.
Published by Elsevier Inc.
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The beginning: biogenesis of HIV-1 RNA
HIV-1 packages its RNA genome into viral particles; upon entering
the target cells, the RNA genome is reverse-transcribed into double-
stranded DNA, which is then integrated into the cellular genome to
form a provirus (reviewed in Cofﬁn et al., 1997; Freed and Martin,
2013). Integration of viral DNA affords retroviruses the ability to
depend on host cell machinery for gene expression including
transcription as well as post-transcriptional processing. The U3, R
and U5 regions in the long terminal repeats (LTRs) of the provirus
are the cis-elements important for the initiation of transcription by
RNA polymerase II and for the modiﬁcation of the RNA molecules
(reviewed in Cofﬁn et al., 1997; Freed and Martin, 2013). Along with
the use of host factors to mediate transcription, HIV-1 also encodes
its own trans-activator of transcription (Tat) for efﬁcient RNA synth-
esis (Gaynor, 1995a; Jones and Peterlin, 1994). Tat interacts with
cyclin T1/CDK9 and binds to the stem-loop structure at the 50 end of
the RNA transcripts called the trans-activating response element
(TAR); this complex promotes the hyperphosphorylation of RNA
polymerase II to ensure efﬁcient elongation of viral transcripts
(Fackler et al., 2001; Hauber and Cullen, 1988; Parada and Roeder,
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1996; Rounseville and Kumar, 1992). The absence of Tat has been
shown to lead to the accumulation of prematurely terminated
transcripts (Adams et al., 1994; Gaynor, 1995b).
Following RNA transcription, HIV-1 transcripts undergo similar
processing steps as cellular RNAs including the addition of the
50 cap, cleavage and the polyadenylation of the 30 end. As with
transcription, HIV-1 relies on the components of the host spliceo-
some machinery for efﬁcient splicing to generate various RNA
molecules. Some of the HIV-1 RNA transcripts undergo splicing
and generate several different RNA species depending on the
selection of the splice sites and the number of splicing events that
occur (Fig. 1) (Cofﬁn et al., 1997). Fully spliced HIV-1 RNAs
accumulate early in the replication cycle and encode the viral
regulatory proteins Tat, Rev and Nef (Fig. 1). Singly spliced or partially
spliced RNA species encode Env and the accessory proteins Vif, Vpr
and Vpu (Fig. 1) (Cullen, 1998). A portion of the HIV-1 RNA transcripts
remains unspliced and these full-length HIV-1 RNAs serve two
functions: they are used as a template for translation of Gag and
GagPol polyproteins, and they are packaged into the virions as the RNA
genome of the next generation (Cullen, 2003; Freed and Martin, 2013).
HIV replication is therefore dependent upon the efﬁcient transcription,
processing, and nuclear export of unspliced, singly spliced and fully
spliced derivatives of the primary transcript.
The journey: RNA export and transport
The export of cellular RNA molecules from the nucleus to the
cytoplasm is a tightly regulated process that serves as a key step
in the control of eukaryotic gene expression. Proper processing of
mRNA is required for the nuclear export (Libri et al., 2002;
Maniatis and Reed, 2002) as post-transcriptional processing
events, including splicing facilitate the recruitment of protein
factors necessary for export (Huang and Steitz, 2005; Lei and
Silver, 2002; Moore and Proudfoot, 2009). This requirement for
posttranscriptional processing poses a conundrum for retroviruses
such as HIV-1 that need to export intron-containing mRNAs
including the unspliced full-length RNA and several other partially
spliced mRNAs. Therefore, HIV-1 uses a trans-acting viral protein,
Rev, and a cis-acting viral Rev response element (RRE), to facilitate
the export of intron-containing RNAs (Felber et al., 1989; Malim
et al., 1989b; Rosen et al., 1988).
Temporal analysis showed that early after HIV-1 infection, only
the fully spliced mRNAs encode for Tat, Rev, or Nef are detected in
the cytoplasm (Kim et al., 1989). These fully spliced RNA tran-
scripts use the NXF1 pathway for export, which is the pathway
used for many cellular mRNAs. Rev is required for the intron-
containing RNAs to be exported from the nucleus to the cytoplasm
(Kim et al., 1989). In the absence of functional Rev, unspliced and
singly spliced RNA transcripts can be detected in the nuclei but are
present in the cytoplasm of infected cells at drastically reduced
levels (Felber et al., 1989; Hadzopoulou-Cladaras et al., 1989; Kim
et al., 1989; Malim et al., 1988).
Rev allows the export of the intron-containing RNAs by acting
as a bridge between the viral RNA and the host export machinery.
A small nuclear shuttling protein, Rev contains a leucine-rich
nuclear export signal (NES) and an arginine-rich RNA binding
region (Kjems et al., 1991; Malim et al., 1990, 1989a; Zapp et al.,
1991). Rev binds cooperatively to and multimerizes on RRE (Cook
et al., 1991; Hadzopoulou-Cladaras et al., 1989; Malim et al., 1990,
1989b; Mann et al., 1994; Tiley et al., 1992). Located in the coding
region of Env, RRE is present in all of the full-length and partially
spliced HIV-1 transcripts. RRE is highly structured and folds into
several stem-loops (Battiste et al., 1996; Daugherty et al., 2010a,
2010b; DiMattia et al., 2010; Hammarskjold and Rekosh, 2011); the
structure of the HIV-1 RRE, which has recently been solved, forms
a tree-dimensional “A” shape; the two legs and the distance
between them all play a critical role in the Rev-RRE recognition
(Fang et al., 2013). In addition to viral RNA, Rev directly interacts
with a karyopherin Crm1 (chromosome region maintenance 1, also
known as exportin 1 or Xpo1), which is a member of the importin
β family of nuclear transport receptors (Fornerod et al., 1997;
Nakielny and Dreyfuss, 1999; Neville et al., 1997). Leptomycin B, a
metabolite of S. Pombe that speciﬁcally inhibits Crm1-mediated
nuclear export, can inhibit Rev-dependent export of RNA tran-
scripts (Daelemans et al., 2002; Kudo et al., 1999; Yashiroda and
Yoshida, 2003). The Rev-RRE forms an export complex with Crm1
and RanGTP, a small GTPase (Ran) in a GTP-containing form; this
export complex is then transported through the nuclear pore
(Fig. 2). Studies have shown that Crm1 interacts with several
Fig. 1. HIV-1 generates multiple RNA species through splicing. A single promoter
from upstream LTR drives HIV-1 transcription. Along with the unspliced full-length
transcript several alternatively spliced transcripts are generated depending on
the number of splicing events that occur and which splice sites are selected.
The dashed lines connect the major splice donor sites to the appropriate splice
acceptor. The proteins expressed by these RNA species are indicated on the left.
Fig. 2. Nuclear export mechanism of full-length and partially spliced HIV-1 RNA.
Viral protein Rev serves as a bridge that recruits Crm1 and RanGTP to intron-
containing HIV-1 RNAs by binding to the RRE. The Rev–RRE–Crm1–RanGTP
complex moves through the nuclear pore complex (NPC). Once in cytoplasm,
RanGap and RanBP1 lead to hydrolysis of Ran-associated GTP into GDP causing the
dissociation of the export complex and the release of HIV-1RNA. Although not
shown, other host proteins, such as DDX3, may be involved in the nuclear export
process (ﬁgure not drawn to scale).
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nucleoporins such as Nup358 and Nup214, which may facilitate
the movement of the export complex through the pore (Bernad
et al., 2004; Fornerod et al., 1997). Once in the cytoplasm, Ran
GTPase-activating protein 1 (Ran GAP1) and Ran binding protein 1
(Ran BP1) modulate the activity of Ran by hydrolyzing the Ran-
associated GTP into GDP, leading to the dissociation of the export
complex (Fig. 2).
Recent studies suggest that an array of additional host factors
may be involved in the regulation of full-length HIV-1 RNA
expression. At this time, the mechanisms of actions of these
proteins are not completely understood; some of these factors
may act before or during RNA export whereas other factors may
act in a more indirect manner such as RNA stabilization. Several
DEAD-box RNA helicase proteins have been reported to be
important to viral RNA expression and/or export. For example,
DDX3 is thought to be required for the export of the Rev/RRE/
Crm1/RanGTP complex (Yedavalli et al., 2004). Knockdown of
DDX3 blocks the Rev-RRE-dependent Gag/Gag-Pol expression.
Given that DDX3 can directly bind to Crm1, it may function by
inﬂuencing the Crm1 export complex (Yedavalli et al., 2004). Other
DEAD-box helicases may also play a role in HIV-1 RNA expression,
including DDX1, DDX5, DDX17, and DDX24 although their mechan-
isms of actions are less understood (Fang et al., 2004; Ma et al.,
2008; Naji et al., 2012; Yasuda-Inoue et al., 2013; Zhou et al., 2013).
Among these, DDX1 has been reported to facilitate the binding and
multimerization of Rev on RRE (Edgcomb et al., 2012; Robertson-
Anderson et al., 2011). The nuclear retention of full-length HIV-1
RNA in the absence of Rev is mediated in part by hnRNP A2/B1
(Gordon et al., 2013). Although not directly involved in RNA
export, other host proteins have been reported to play a role in
full-length HIV-1 RNA expression. For example, analysis of the
proteome associated with HIV-1 RNAs identiﬁed nuclear matrix
protein Matrin 3 (MATR3) in Rev/RRE complexes (Kula et al., 2011),
which is thought to stabilize unspliced and partially spliced HIV-1
RNAs (Yedavalli and Jeang, 2011). Peroxisome proliferator-
activated receptor-interacting protein with methyltransferase
domain (PIMT) can also interact with Rev and lead to hypermethy-
lation the 50 cap of full-length/partially spliced HIV-1 RNA to
facilitate their expression (Yedavalli and Jeang, 2010).
Although HIV-1 uses the Crm1 pathway to export its intron-
containing RNAs, other retroviruses may use different export
pathways. For example, Mason-Pﬁzer Monkey Virus (MPMV) uses
a structured RNA element termed constitutive transport element
(CTE) that employs the cellular NXF1/Tap export pathway to avoid
nuclear retention of intron-containing RNAs (Bray et al., 1994).
This pathway is Crm1-independent, as treatment with Leptomycin
B does not inhibit nuclear export of CTE-containing RNAs (Grüter
et al., 1998; Otero et al., 1998; Pasquinelli et al., 1997; Saavedra
et al., 1997). Though MPMV uses CTE to export its RNAs through a
different pathway, CTE alone can functionally replace Rev/RRE
during HIV-1 replication (Bray et al., 1994; McBride et al., 1997;
Moore et al., 2009; Srinivasakumar et al., 1997; Ward et al., 2009;
Wodrich et al., 2000).
Upon entering the cytoplasm, HIV-1 RNA must be transported
to subcellular compartments to serve its functions. Interestingly,
proper HIV-1 RNA export appears to tie to not only the RNA
function in the cytoplasm but also the function of the protein
encoded by that RNA. This phenomenon was ﬁrst observed in
modiﬁed mouse cells expressing the human cyclin T1 gene which
allows for efﬁcient HIV-1 RNA transcription elongation (Bieniasz
et al., 1998; Swanson et al., 2004; Wimmer et al., 1999). HIV-1 RNA
can be exported and translated in these cells, but the Gag proteins
do not target to the plasma membrane properly resulting in an
assembly defect (Mariani et al., 2000; Swanson et al., 2004). This
defect can be rescued by re-routing the HIV-1 RNA export through
the NXF1 pathway by replacing RRE with MPMV CTE (Swanson
et al., 2004) or by supplementing rodent cells with human Crm1
protein (Elinav et al., 2012; Nagai-Fukataki et al., 2011; Okada
et al., 2009; Sherer et al., 2011). A similar phenotype was also
observed in human cells when HIV-1 RNA was exported using an
unknown pathway (Jin et al., 2009). Therefore, RNA export is
closely associated with RNA transport and RNA functions. At this
time, the precise mechanism of HIV-1 RNA transport in the
cytoplasm is not completely understood. For example, it was
reported that later during replication after the expression of Gag,
HIV-1 full-length RNA and Gag co-trafﬁc using the microtubules to
the virion assembly sites (Lehmann et al., 2009; Molle et al., 2009).
However, disrupting microtubules by treating the cells with
nocodazole does not inhibit HIV-1 virus production (Molle et al.,
2009). Therefore, further studies are needed to understand how
HIV-1 RNA is transported in the cytoplasm.
The rendezvous: RNA partner selection/dimerization and RNA–
Gag interaction
HIV-1 packages two copies of unspliced, single-stranded, full-
length RNA genome into each viral particle (Chen et al., 2009).
Both copies of genomic RNA are full-length, and each encodes all
of the genetic information needed for viral replication. Packaging
two complete RNA genomes provides the opportunity for frequent
template switching events during reverse transcription, resulting
in the generation of recombinant viruses that are genetically
distinct from the two parental viruses (Hu and Temin, 1990a,
1990b; Rhodes et al., 2003). Strand transfer between the two RNA
molecules may also act as a rescue mechanism to recover genetic
information from an RNA molecule in which the integrity is
compromised (Cofﬁn, 1979; Hu and Temin, 1992).
HIV-1 uses the cis-acting elements in the viral RNA and the
trans-acting elements in Gag to achieve speciﬁc packaging of the
viral RNA genome. The RNA elements important for packaging of
HIV-1 genomic RNA have been mapped to the highly conserved
and structured 50 untranslated region (50UTR) and extend into the
50 end of the gag coding sequence (Aldovini and Young, 1990;
Buchschacher and Panganiban, 1992; Clavel and Orenstein, 1990;
Hayashi et al., 1992; Lever et al., 1989; Luban and Goff, 1994, 1991;
McBride et al., 1997). The region required for RNA packaging and
RNA dimerization overlap in HIV-1; multiple studies reported that
the RNA fragments containing the aforementioned region can
dimerize in vitro (Awang and Sen, 1993; Darlix et al., 1990;
Marquet et al., 1991; Sundquist and Heaphy, 1993). The linkage
of the 50 ends of the two RNAs from several retroviruses can be
visualized in electron micrographs (Bender and Davidson, 1976;
Bender et al., 1978; Chien et al., 1980; Dube et al., 1976; Hoglund
et al., 1997; Murti et al., 1981). Initially the entire 50 packaging
signal was refered to as Ψ (psi). Following extensive biochemical
probing, mutagenesis, structural, phylogenetic and in silico analy-
sis of this leader region, elements important for packaging became
better deﬁned (Baudin et al., 1993; Clever et al., 1995a; Harrison
and Lever, 1992). Among the important elements in the HIV-1
leader that contribute to efﬁcient RNA packaging are four stem
loops (SL1, SL2, SL3, SL4) (Clever et al., 1995b; McBride et al., 1997).
SL1 displays a GC-rich 6-nt palindromic sequence at the top of its
loop called the dimer initiation signal (DIS). SL2 contains the major
splice donor (SD) (Purcell and Martin, 1993). SL3, now denoted as
psi (Ψ) is the most conserved region of the leader sequence and
contains a GGAG RNA tetraloop that binds NC with high afﬁnity
(De Guzman et al., 1998). SL4 is downstream of SL3 and contains
the AUG start codon of gag; although a documented structure,
SL4 may not be present in the RNA competent to dimerize and be
packaged (as discussed later). In addition to mediating RNA
dimerization and packaging, the 336-nt 50 leader sequence of the
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HIV-1 genome also is important for transcription (TAR), splicing
(SD), and contains the reverse transcription primer binding (PBS),
making it difﬁcult to parse out what direct and indirect effects
mutations in this region have on genome packaging. Many studies
have linked the TAR hairpin to dimerization and packaging (Clever
et al., 1999; Damgaard et al., 2004; Das et al., 1998; McBride et al.,
1997). However, once the regulation of Tat/TAR on transcription
was replaced with a tetracycline-inducible system, it became
apparent that the TAR hairpin is not required for packaging (Das
et al., 2007). Further studies conﬁrm that the TAR hairpin as well
as the Poly(A) signal are dispensable for RNA dimerization and
packaging (Heng et al., 2012; Sakuragi et al., 2007).
Of the RNA elements described above, the DIS in SL1 is able to
mediate in vitro dimerization of RNA fragments (Laughrea and
Jetté, 1994; Muriaux et al., 1995; Paillart et al., 1994; Skripkin et al.,
1994). Furthermore, the DIS sequence has proven to be the
dominant factor driving RNA dimerization and RNA partner selec-
tion in vivo (Chen et al., 2009; Chin et al., 2005; Moore et al., 2007).
The autocomplementary nature of the DIS supports the initiation
of Watson–Crick base pairing between the two HIV-1 RNA
molecules and the generation of a “kissing loop” (Clever et al.,
1996; Kieken et al., 2006; Paillart et al., 1997). The most common
DIS sequence is GCGCGC in subtype B, and GUGCAC in subtypes A, C
and G HIV-1. The differences in the DIS primary sequences have
proven to be a major barrier for recombination between two viral
subtypes such as subtype B and subtype C HIV-1, reinforcing the role
of the DIS in the initiation of RNA dimerization (Chin et al., 2005).
The inﬂuence of the DIS sequences on RNA copackaging is strong
evidence that the viral RNAs select co-packaged RNA partners (or
initiate RNA dimerization) before they are packaged into the viral
particles (Chen et al., 2009; Moore et al., 2007). Furthermore, RNA
partner selection occurs in the cytoplasm (Moore et al., 2009). Using
cells harboring different proviruses and fusing cells at conditions that
allow for the mixing of cytoplasmic but not nuclear content, it was
shown that RNA dimerization occurs in the cytoplasm of the cell, not
the nucleus (Moore et al., 2009). It is of note that RNAs using different
export pathways are able to be copackaged, but to a lesser extent
compared with RNAs using the same export pathways, suggesting that
RNA partner selection in the cytoplasm occurs where the RNA
molecules are still at least partially segregated (Moore et al., 2009).
Fig. 3. Cis- and trans- factors of HIV-1 RNA packaging. (A) and (B) Two models of the HIV-1 50 leader RNA secondary structures favoring translation (left) or RNA dimerization
and packaging (right). AUG start codon of gag (green), DIS (red), Ψ (purple), U5 (red). (A) Conformation switch of the HIV-1 50 leader RNA proposed by the Berkhout group
(Abbink and Berkhout, 2003). In the long distance interaction (LDI) structure (left) the DIS sequence is sequestered through base-pair interactions with the Poly(A). However,
in the branched multiple hairpin (BMH) structure (right) the AUG start codon of gag binds the U5 region, exposing the DIS sequence and promoting RNA dimerization and
packaging. (B) Conformation switch proposed by the Summers group (Lu et al., 2011). Alternative RNA secondary structures of the HIV-1 50 leader RNA favoring translation
(left) in which DIS is base-paired with the U5 region or dimerization and packaging (right) in which the AUG base-pairs with the U5 region the DIS sequence is exposed.
(C) Domains of the HIV-1 Gag polyprotein. MA (Matrix), CA (Capsid), SP1 (Spacer 1), NC (Nucleocapsid), SP2 (Spacer 2), p6.
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A speciﬁc region of the murine leukemia virus (MLV) genome
has been identiﬁed as necessary and sufﬁcient for RNA packaging
because insertion of this sequence can confer the ability of
heterologous RNA to be packaged into viral particles (Adam and
Miller, 1988; Hibbert et al., 2004). At this time, the necessary and
sufﬁcient HIV-1 packaging signal has not been deﬁned. However,
within the viral context, deletions have been made to trim down
the sequences required for packaging of the HIV-1 genome. A
minimal 159-nt RNA sequence that includes SL1–SL3 through the
U5:AUG stem, but lacks TAR, Poly(A) and the upper PBS hairpin
structure, can dimerize and is competent to bind NC in vitro (Heng
et al., 2012). In addition, a 144-nt RNA sequence including a
segment of sequence that forms the base of the PBS hairpin (but
does not include the primer binding site), SL1, SL3 and SL4 proved
to be sufﬁcient to mediate intramolecular dimerization when
inserted into an ectopic position in the HIV-1 genome, and was
deﬁned as the minimal element required for HIV-1 RNA dimeriza-
tion in vivo (Sakuragi et al., 2007).
The HIV-1 RNA packaging signal is recognized by Gag, which is
synthesized as a polyprotein that is later processed into six mature
proteins: matrix (MA), capsid (CA), SP1, nucleocapsid (NC), SP2,
and p6 (Fig. 3C). Of these domains, NC plays the major role for the
selective packaging of the HIV-1 RNA genome (Berkowitz et al.,
1993; Luban and Goff, 1994). The NC protein contains two CCHC-
type zinc knuckle motifs separated by a linker. Mutations of the NC
domain including those in the CCHC sequences can cause severe
defects in viral RNA packaging (Aldovini and Young, 1990;
Dorfman et al., 1993; Gorelick et al., 1990). Furthermore, replacing
the NC domain of HIV-1 Gag with the NC domain of MLV, allows
this chimeric polyprotein to package MLV RNA genome, and vice
versa (Berkowitz et al., 1995; Zhang and Barklis, 1995). However,
the speciﬁcity of viral RNA packaging cannot always be changed by
replacing the NC domain. For example, swapping the NC domains
of HIV-1 and mouse mammary tumor virus (MMTV) does not alter
the packaging preferences of these viruses (Poon et al., 1998).
Containing a basic patch for membrane targeting, the MA domain
has also been shown to have nucleic acid binding properties (Cai
et al., 2010; Chukkapalli et al., 2010, 2008; Lochrie et al., 1997;
Purohit et al., 2001). However, currently there is no evidence
supporting that HIV-1MA plays a role in speciﬁc packaging of viral
genome.
In addition to serving as the RNA genome, full-length HIV-1
RNA also serves as the mRNA template for Gag/GagPol translation
(Butsch and Boris-Lawrie, 2000; Dorman and Lever, 2000). It is not
well understood how these two functions of viral RNA are
balanced. Multiple studies support a model in which two, or more,
alternative structures for the HIV-1 RNA leader sequences exist,
the two aforementioned RNA functions are carried out by RNA
folded into different structures (Baudin et al., 1993; Berkhout and
van Wamel, 2000; Berkhout et al., 2001; Huthoff and Berkhout,
2001a, 2001b; Huthoff et al., 2004; Ooms et al., 2004). Berkhout
and colleagues have proposed that the 50 end of HIV-1 RNA can
fold into two alternative structures: the long distance interaction
(LDI) structure or the branched multiple hairpin (BMH) structure
(Fig. 3A). In the LDI conformation, the DIS participates in a long-
distance interaction with the upstream Poly(A) domain and there-
fore cannot engage in the “kissing loop” interactions that induce
RNA dimerization (Huthoff and Berkhout, 2001a). However, in the
BMH conformation, the DIS sequences are exposed, promoting
RNA dimerization and packaging. Although, it has been shown that
NC may disrupt the LDI conformation and promote RNA dimeriza-
tion in vitro, the existence of the BMH and LDI structures have
yet to be shown in vivo (Berkhout et al., 2001). A recent model
proposed that the RNA conformation that favors translation
sequesters the DIS sequence by interaction with part of the U5,
not the Poly(A) region, whereas the AUG start codon participates
in base-pairing in the stem of SL4 (Fig. 3A) (Lu et al., 2011). In the
alternative structure, the SL4 is lost as the AUG sequences base-
pair with part of U5, displacing and exposing the DIS sequence and
promoting dimerizations and packaging (Damgaard et al., 2004;
Lu et al., 2011; Wilkinson et al., 2008).
It has been shown that MLV has two pools of RNAs, one serves
as template for protein translation and the other serves as the RNA
genome (Levin and Rosenak, 1976; Levin et al., 1974). Currently,
there is no evidence that such division exists in the HIV-1 RNA
population (Butsch and Boris-Lawrie, 2000; Dorman and Lever,
2000). In contrast, a cis packaging model was proposed in which
the Gag polyprotein preferentially packages the RNA template
from which it was translated (Poon et al., 2002). However, it was
later shown that Gag efﬁciently packages RNA in trans and that
trans-packaging is the primary mechanism used for HIV-1 RNA
packaging (Nikolaitchik et al., 2006).
The precise location where the Gag and RNA genome interac-
tion takes place is currently not known. It was proposed that HIV-
1 full-length RNA and Gag ﬁrst interact and colocalize in the
perinuclear region and this complex subsequently trafﬁcs through
the cytoplasm to the plasma membrane of the cell (Poole et al.,
2005). This proposal was challenged later as HIV-1 RNA genome
but not Gag was detected at the perinuclear region (Kemler et al.,
2010). Using a co-immunoprecipitation assay coupled to mem-
brane ﬂotation, it was shown that HIV-1 RNA can be pulled down
with Gag from the cytoplasmic fraction; additionally, the ability to
co-precipitate viral RNA does not depend on the ability of Gag to
target to the membrane but is stabilized by the Gag–Gag interac-
tion. These experiments suggest that the initial Gag and RNA
genome interaction may occur in the cytoplasm (Kutluay and
Bieniasz, 2010).
The destination: HIV-1 full-length RNA assembles into virus
particles
To infect a new host, HIV-1 needs to generate new virions,
which is a sophisticated process that involves the assembly of the
appropriate numbers of viral proteins, viral RNA, host RNA
including tRNA, and recruitment of host proteins to facilitate the
exit of the newly generated particles from the cell. By directly
visualizing the viral RNA content of individual particles, it was
found that most HIV-1 particles contain viral genomes; further-
more, two copies of RNAs are packaged into one particle (Chen
et al., 2009). Therefore, the packaging of the viral RNA is a tightly
regulated process. As mentioned above, the interactions between
Gag and RNA elements ensure the speciﬁcity of the RNA genome
packaging; however, the mechanism by which HIV-1 regulates the
packaging of the two copies of RNAs was unknown. Using RNA
genomes of different lengths, it was shown that two copies of RNA
were packaged regardless whether the genome was 3 kb, 8 kb, or
17 kb, indicating that viral genome packaging is not regulated by
the mass of the RNA (Nikolaitchik et al., 2013). It was further
shown that if two dimerization signals were present in a single
viral RNA, it can form a self-dimer, and only one copy of the self-
dimer is packaged (Nikolaitchik et al., 2013). Taken together, these
results indicate that HIV-1 RNA genome packaging is regulated by
the recognition of one dimeric RNA.
Although controversial at one point, our current understanding
is that the major assembly site for HIV-1 is the plasma membrane
(Jouvenet et al., 2006; Ono, 2010). Furthermore, these assembly
events preferentially take place in discrete domains of the plasma
membrane enriched in cholesterol and sphingolipids, known as lipid
rafts (Nguyen and Hildreth, 2000; Ono and Freed, 2001; Ono, 2009).
The viral protein Gag orchestrates the assembly process including
membrane targeting, Gag–Gag and Gag–GagPol multimerization,
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recruitment of Env, and the packaging of viral RNA genome
(reviewed in Sundquist and Kräusslich, 2012).
The assembly and RNA packaging process have been visualized
using total internal reﬂection ﬂuorescence (TIRF) microscopy. By
tagging Gag with a ﬂuorescent protein and monitoring the signal
emitted, the kinetics of virus assembly were examined. In these
experiments, individual weak ﬂuorescent signals ﬁrst appeared on
the plasma membrane and the intensity of the signals increased with
time; eventually, the intensities of these signals reached a plateau
and were in the range of those observed in viral particles. The
measured assembly time varied but averaged between 5 and 6 min
to 8 and 9 min (Ivanchenko et al., 2009; Jouvenet et al., 2008).
Gradual increase of Gag signals on the plasma membrane is
consistent with the biochemical studies indicating Gag multimerizes
extensively on the membrane but not the in the cytoplasm (Kutluay
and Bieniasz, 2010). The packaging of the viral RNA genome was
studied by labeling the RNA with a ﬂuorescently tagged bacterioph-
age MS2 coat protein which speciﬁcally interacts with the MS2
binding sites engineered into the HIV-1 genome. In these experi-
ments, it was observed that viral RNA genomes can reach the plasma
membrane even when Gag is not expressed; these RNA signals
moved in a dynamic manner and only resided on the membrane for
few seconds (Jouvenet et al., 2009). When Gag and RNA were both
expressed, RNA signals appeared on the membrane ﬁrst; weak Gag
signals were detected and co-localized with the RNA approximately
4–5 min after the appearance of RNA signal. As the Gag signal
intensities increased with time, the lateral mobility of the viral RNA
decreased until the completion of the viral particle assembly
(Jouvenet et al., 2009). It should be noted that although the RNA
signals were detected prior to those of Gag in these experiments, it
remains possible that at this time, a few Gag proteins were associated
with RNA, but their signal intensity was below the limit of detection.
Together these observations suggest that no more than a few Gag
molecules bind RNA in the cytoplasm and together they are targeted
to the membrane where Gag multimerization proceeds as Gag
assembles around the viral RNA genome.
In summary, HIV-1 full-length RNA plays a central role in viral
replication. Its complicated journey from the nucleus to the viral
particles requires the sophisticated manipulation of cellular functions
and dynamic interactions of viral components. There is still much to
be learned about the various stages of the life of the full-length HIV-1
RNA, such as host proteins involved in nuclear RNA export, the
mechanism of cytoplasmic RNA transport, the relationship between
RNA structures and functions, the location(s) where Gag–RNA inter-
action takes place, and the molecular interactions between Gag and
RNA that lead to speciﬁc packaging. Future studies will shed light on
many of the currently unanswered questions.
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